Zosano Announces Publication of Positive Data on Qtrypta’s™ Potential as an Acute Treatment for Patients with Difficult-to-Treat Migraines Pharmaceutical Investing
IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT NDA Life Science Investing
ASLAN Pharmaceuticals Announces Strategic Prioritisation of Clinical Development Programs and Corporate Restructuring Life Science Investing
scPharmaceuticals Announces Development Agreement with West Pharmaceutical Services Life Science Investing
Kiniksa Pharmaceuticals Announces Proposed Public Offering and Concurrent Private Placement Life Science Investing
PreveCeutical to Explore Partnerships with Pharmaceutical and Biotechnology Companies for the Co-Development of its Sol-Gel System Cannabis Investing News
Harvest One Cannabis Inc. to Webcast Live at VirtualInvestorConferences.com January 30th Cannabis Investing News
Allogene Therapeutics in Collaboration with Servier Announces FDA Clearance of the IND for ALLO-501 Life Science Investing
MacroGenics Announces Removal of Partial Clinical Hold on MGD009 Program by FDA Pharmaceutical Investing
